Inhalation device, pulmonary deposition and clinical effects of inhaled therapy

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 10, Issue SUPPL. 1, 1997, Pages

  Pauwels, Romain ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; SALBUTAMOL; TERBUTALINE; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; MULTICENTER STUDY; POWDER INHALER; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; ROTAHALER; TREATMENT OUTCOME;

EID: 0031051224     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1997.10.suppl_1.s-17     Document Type: Conference Paper

References (12)

1. AGERTOFT L, PEDERSEN S. Importance of the inhalation device on the effect of budesonide. Arch Dis Child 1993;69:130-3.
2. AGERTOFT L, PEDERSEN S. Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994;71:217-20.
3. BORGSTRÖM L, DEROM E, STAHL E, WÅHLIN-BOLL E, PAUWELS R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Amer J Respir Crit Care Med 1996;153:1636-40.
4. BRAMBILLA C, LACRONIQUE J, ALLAERT FA, GODARD P, DUROUX P. The French Budesonide Trial Group: A 3-month comparative dose-reduction study with inhaled beclomethasone dipropionate and budesonide in the management of moderate to severe adult asthma. Drug Invest 1994;8:49-56.
5. LÖFDAHL CG, ARVIDSSON P, BONDESSON E, FRIBERG K. Higher potency of salbutamol when given via Turbuhaler, than via pressurized metered dose inhaler (pMDI). Allergy Clin Immunol News 1994a;6(Suppl 2):383.
6. LÖFDAHL CG, ANDERSSON L, BONDESSON E et al. Salbutamol doses inhaled via Turbuhaler, give a better bronchodilating effect than when given via a pressurized metered dose inhaler. Eur Respir J 1994b;7(suppl 18):49S.
7. PAUWELS RA, HARGREAVE FE, CAMUS P, BUKOSKI M, STAHL E. A 1-year comparison of Turbuhaler vs pressurised metered-dose inhaler in asthmatic patients. Chest 1996;110:53-7.
8. PIQUET J, PFEIFFER G, OSTINELLI J, BOOK A. Half the dose of budesonide Turbuhaler versus a full dose of beclomethasone dipropionate pMDI in the treatment of asthma. Am J Respir Crit Care Med 1995;151(No 4 pt 2):A56
9. SELROOS O, BACKMAN R, LÖFROOS AB et al. Clinical efficacy of budesonide Turbuhaler, compared with that of beclomethasone dipropionate pMDI with olumatic spacer. A 2-year randomized study in 102 asthma patients. Allergy 1994a;49:833-6.
10. SELROOS O, BACKMAN R, FORSÉN K-O et al. Local side-effects during 4-year treatment with inhaled corticosteroids - a comparison between pressurized metered-dose inhalers and Turbuhaler®. Allergy 1994b;49:888-90.
11. THORSSON L, EDSBÄCKER S, CONRADSON TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler (pMDI). Eur Respir J 1994;7:1839-44.
12. ZAINUDIN BM, BIDDISCOMBE M, TOLFREE SE, SHORT M, SPIRO SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 1990;45:469-73.